Skip to main content

Compugen Licenses 2-D Gel System to Organon, Procter & Gamble

NEW YORK, Nov. 6-Compugen has licensed its Z4000 automated 2-D gel system to both Organon and Procter & Gamble Pharmaceuticals, the company said today.

 

The system, launched last February, allows for the design, analysis, and management of large-scale 2-D gel proteomics experiments.

 

Compugen is based in Tel Aviv, Israel.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.